AKI!Now 倡议:关于急性肾损伤的认知、识别与管理的推荐
美国肾脏病学会发起的AKI!Now倡议,旨在通过构建转化教育和AKI照护提供的基础项目来促进AKI预防和治疗的卓越性,减少发病率及相关死亡率并改善长期结局。文章描述了当前改善早期识别和管理的努力,涉及提供者、患者及其家庭之间的包容性跨学科协作;讨论了改变现有AKI范式和诊断方法的持续需求;并提供了改善AKI识别和照护的具体推荐。AKI是常见且日益频繁的疾病,带来不良事件风险和高额费用,但患者可能经常接受次优质量的照护。新分类有助于理解AKI发病率及其对结局的影响,但不总是与AKI病理生理学良好对齐;尽管研究持续进行,促进或加速肾脏恢复的治疗仍无效。当前方法强调促进早期识别和及时反应以避免进展,但医疗团队成员对早期识别和治疗重要性的认识不足以及团队内评估方法的异质性仍是主要挑战。
要点
- AKI!Now倡议旨在通过转化教育和照护提供的基础项目减少AKI相关发病率、死亡率并改善长期结局。
- 当前AKI治疗强调促进早期识别和及时反应以避免进展。
- 医疗团队成员对早期识别和治疗重要性的认识不足以及团队内评估方法的异质性仍是主要挑战。
- 早期识别因AKI发生场所(社区或医院)以及ICU与病房环境之间患者群体和文化的差异而进一步复杂化。
- 推荐包括开发广泛适用的教育和AKI管理工具包、让医院管理者将AKI纳入质量改进举措、提高对AKI作为其他疾病过程并发症的认识。
适用人群与场景
- 医院和社区中发生AKI的患者。
- 涉及提供者、患者及其家庭之间的跨学科协作。
- ICU与病房环境中的患者群体存在差异。
处置流程与药物剂量
- 开发广泛适用的教育和AKI管理工具包。
- 让医院管理者将AKI纳入质量改进举措。
- 提高对AKI作为其他疾病过程并发症的认识。
- 促进早期识别和及时反应以避免AKI进展。
研究设计与关键结果
- 美国肾脏病学会建立了AKI!Now新倡议,目标是促进AKI预防和治疗的卓越性。
- AKI是医院和社区中常见且日益频繁的疾病,带来不良事件风险和高额费用。
- 患者可能经常接受次优质量的AKI照护。
- 新分类有助于理解AKI发病率及其对结局的影响,但不总是与AKI病理生理学良好对齐。
- 促进或加速肾脏恢复的治疗仍无效。
证据类型、等级与局限
- 证据类型:指南/共识(美国肾脏病学会倡议)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需要改善各级照护的教育,并生成关于AKI评估和管理的具体指导。
- 作者认为需要开发广泛适用的教育和AKI管理工具包。
- 作者认为需要让医院管理者将AKI纳入质量改进举措。
- 作者认为需要提高对AKI作为其他疾病过程并发症的认识。
指南或共识出处
- AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI(美国肾脏病学会)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The American Society of Nephrology has established a new initiative, AKI!Now, with the goal of promoting excellence in the prevention and treatment of AKI by building a foundational program that transforms education and delivery of AKI care, aiming to reduce morbidity and associated mortality and to improve long-term outcomes. In this article, we describe our current efforts to improve early recognition and management involving inclusive interdisciplinary collaboration between providers, patients, and their families; discuss the ongoing need to change some of our current AKI paradigms and diagnostic methods; and provide specific recommendations to improve AKI recognition and care. In the hospital and the community, AKI is a common and increasingly frequent condition that generates risks of adverse events and high costs. Unfortunately, patients with AKI may frequently have received less than optimal quality of care. New classifications have facilitated understanding of AKI incidence and its impact on outcomes, but they are not always well aligned with AKI pathophysiology. Despite ongoing research efforts, treatments to promote or hasten kidney recovery remain ineffective. To avoid progression, the current approach to AKI emphasizes the promotion of early recognition and timely response. However, a lack of awareness of the importance of early recognition and treatment among health care team members and the heterogeneity of approaches within the health care teams assessing the patient remains a major challenge. Early identification is further complicated by differences in settings where AKI occurs (the community or the hospital), and by differences in patient populations and cultures between the intensive care unit and ward environments. To address these obstacles, we discuss the need to improve education at all levels of care and to generate specific guidance on AKI evaluation and management, including the development of a widely applicable education and an AKI management toolkit, engaging hospital administrators to incorporate AKI as a quality initiative, and raising awareness of AKI as a complication of other disease processes.
参考来源
- Liu KD, Goldstein SL, Vijayan A, et al. AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI. Clin J Am Soc Nephrol. 2020. PMID: 32317329. doi:10.2215/CJN.15611219
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。